Alpine Immune Sciences, Inc.
(Deutsche Boerse AG : NVLS)

( )
NVLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.73%104.101.1%$1332.57m
GILDGilead Sciences, Inc.
0.04%72.440.9%$675.30m
AMGNAmgen Inc.
-0.45%170.001.1%$499.55m
BIIBBiogen Inc.
0.00%313.971.2%$468.09m
REGNRegeneron Pharmaceuticals, Inc.
-0.79%391.592.7%$363.74m
ALXNAlexion Pharmaceuticals, Inc.
0.49%110.871.9%$288.55m
VRTXVertex Pharmaceuticals Incorporated
-0.36%147.411.9%$237.28m
INCYIncyte Corporation
-0.95%105.472.5%$187.59m
ALNYAlnylam Pharmaceuticals, Inc
0.89%127.5110.6%$184.43m
ILMNIllumina, Inc.
0.25%209.023.5%$165.18m
NKTRNektar Therapeutics
0.13%44.996.1%$146.11m
JUNOJuno Therapeutics, Inc.
1.56%58.6413.5%$138.44m
BMRNBioMarin Pharmaceutical Inc.
0.39%82.884.4%$117.68m
SRPTSarepta Therapeutics, Inc.
1.94%56.1116.8%$117.17m
BLUEBluebird Bio, Inc.
1.90%163.2017.2%$116.94m

Company Profile

Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO.